Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Excess risk of chronic physical conditions associated with depression and anxiety

BMC Psychiatry201414:10

DOI: 10.1186/1471-244X-14-10

Received: 7 May 2013

Accepted: 6 January 2014

Published: 16 January 2014

Abstract

Background

Depression and anxiety have been reported to be associated with chronic physical conditions. We examined the excess risk of chronic physical conditions associated with depression and/or anxiety within a multivariate framework controlling for demographic and modifiable lifestyle risk factors.

Methods

We used a retrospective cross-sectional study design. Study participants were adults aged 22–64 years from 2007 and 2009 Medical Expenditure Panel Survey. We defined presence of depression-anxiety based on self-reported depression and anxiety and classified adults into 4 groups: 1) depression only; 2) anxiety only; 3) comorbid depression and anxiety 4) no depression and no anxiety. We included presence/absence of arthritis, asthma, chronic obstructive pulmonary disorder, diabetes, heart disease, hypertension, and osteoporosis as dependent variables. Complementary log-log regressions were used to examine the excess risk associated with depression and/or anxiety for chronic physical conditions using a multivariate framework that controlled for demographic (gender, age, race/ethnicity) and modifiable lifestyle (obesity, lack of physical activity, smoking) risk factors. Bonferroni correction for multiple comparisons was applied and p ≤0.007 was considered statistically significant.

Results

Overall, 7% had only depression, 5.2% had only anxiety and 2.5% had comorbid depression and anxiety. Results from multivariable regressions indicated that compared to individuals with no depression and no anxiety, individuals with comorbid depression and anxiety, with depression only and with anxiety only, all had higher risk of all the chronic physical conditions. ARRs for comorbid depression and anxiety ranged from 2.47 (95% CI: 1.47, 4.15; P = 0.0007) for osteoporosis to 1.64 (95% CI: 1.33, 2.04; P < 0.0001) for diabetes. Presence of depression only was also found to be significantly associated with all chronic conditions except for osteoporosis. Individuals with anxiety only were found to have a higher risk for arthritis, COPD, heart disease and hypertension.

Conclusion

Presence of depression and/or anxiety conferred an independent risk for having chronic physical conditions after adjusting for demographic and modifiable lifestyle risk factors.

Keywords

Depression Anxiety Obesity Smoking Physical activity Chronic physical conditions

Background

Depression and anxiety have been reported to be associated with chronic physical conditions [1]. Evidences from cross-sectional, longitudinal studies, systematic reviews, and meta-analyses have concluded that depression is an independent risk factor for developing chronic physical conditions [29]. Published research has shown that depression can lead to type 2 diabetes (hereafter referred to as diabetes) [3], cardiovascular diseases (CVD) [4] and hypertension [5]. In a Canadian study it was found that among young adults between 20 and 50 years, prior history of depression was related to new onset diabetes [10]. Results from meta-analyses showed that individuals with depression had a 64% increased risk of development of heart disease [11] and 60% increased risk of diabetes [12]. Several studies also have reported depression as a significant predictor of osteoporosis and fractures [69]. An association between depression and Chronic Obstructive Pulmonary Disease (COPD) is established through an indirect pathway via increased nicotine dependence among those with depression. [1315].

However, there has been mixed findings on the association between anxiety and risk for some chronic physical conditions. A prospective association between anxiety and risk of hypertension has been reported [16]. A Danish study also revealed an increased likelihood of hypertension among those with anxiety disorders [17]. The association between anxiety and risk of developing diabetes has been inconclusive. While some studies showed an increased risk of diabetes among those with anxiety as compared to those without anxiety [18], other studies have not shown any association between anxiety and diabetes [19]. Studies have reported an indirect association between anxiety and osteoporosis; compared to adults without anxiety, those with anxiety had lower hip bone mass density [20], which is a risk factor for osteoporosis [21]. A recently concluded meta-analysis indicated that depression or anxiety results in a 43% increased incidence or exacerbation risk of COPD, particularly among non-elderly adults [22].

In addition, depression and anxiety co-occur in more than 50% of individuals with depression [2325]. To the best of our knowledge, only one study using mental health survey in 17 countries addressed the association between comorbid depression and anxiety on risk for chronic physical conditions [26]. This study concluded that comorbid depression and anxiety was associated with increased likelihood of 10 different chronic physical conditions (asthma, arthritis, back/neck problems, chronic headache, diabetes, heart disease, hypertension, multiple pains, obesity and ulcer). For example, the age and gender adjusted odds ratios (AOR) and 95% Confidence Interval (CI) for comorbid depression and anxiety was 1.6(1.4, 1.9) for asthma 2.5(2.2, 2.9) for arthritis and 2.8(2.3, 3.4) for heart disease, compared to those without depression and without anxiety.

A general limitation of many of the studies described above has been the lack of comprehensive controls when analyzing the association between depression, anxiety and chronic physical conditions. Individuals with depression and/or anxiety also have higher rates of obesity [27, 28], smoking [29, 30] and lower rates of physical activity [31] compared to those without depression and without anxiety. In addition, studies have documented that modifiable lifestyle risk factors such as obesity, lack of physical activity, and smoking can contribute to the increased risk for chronic physical conditions [3234]. Therefore it is very important to control for these risk factors in order to assess the excess risk of chronic physical conditions associated with the presence of depression and anxiety.

The primary purpose of our study was to examine excess risk of a diverse set of chronic physical conditions associated with depression and/or anxiety in a non-elderly adult population within a multivariate framework that controlled for demographic and modifiable lifestyle risk factors. We focus on the non-elderly adult population because individuals with depression and/or anxiety may develop chronic physical conditions at an earlier age as compared to general population [2]. We hypothesize that even after controlling for these risk factors individuals with depression and/or anxiety will have a greater risk of arthritis, asthma, COPD, diabetes, heart disease, hypertension and osteoporosis as compared to individuals with neither depression nor anxiety.

Methods

Study design

We used a retrospective cross-sectional study design using data from a nationally representative household survey in the United States (US).

Data source and setting

The current study utilized data from the annual releases of 2007 and 2009 Medical Expenditure Panel Survey (MEPS), a nationally representative annual survey of households representing the US non-institutionalized civilian population. The survey adopted a multistage, clustered sample design [35].

The household component (HC) is the core of the MEPS data. Extensive health care utilization data, including demographics, health conditions, health status, use of medical care and prescription medications, detailed charges and payment, insurance coverage, income, and employment are captured in the HC through annual computer-assisted in-person (CAPI) interviews. Information on medical conditions can be derived from the Medical Conditions file of the HC of MEPS. Details of how medical conditions were derived from these files are provided in the Measures section below.

Analytic sample

We restricted our analytical sample to individuals who were between the ages of 22 and 64 years, were not underweight (i.e. BMI <18.5 kg/m2), and were alive as of the end of the calendar years 2007 and 2009. Based on these selection criteria, participants from 2007 and 2009 MEPS data were pooled together to yield a final sample of 33,242 participants. In our study sample, a very small number (only 1.2%) of adults were in the underweight BMI group and therefore we excluded underweight BMI group from our analytic sample. Individuals with self-reported schizophrenia, psychoses, attention deficit hyper activity disorders, adjustment disorders, substance abuse disorders and personality disorders were excluded from analysis.

Measures

Dependent variables:presence/absence of chronic physical conditions

As mentioned above, chronic physical conditions were derived from medical conditions file. The MEPS investigators followed many procedures to minimize under-reporting of medical and mental health conditions. Conditions can be reported: (1) in the Priority Condition Enumeration section in which respondents are asked if they have been diagnosed by a doctor or other health care professional with specific conditions. The priority conditions for 2007 and 2009 included (i) long term life threatening conditions like Cancer, Hypertension/High Blood Pressure, Diabetes/Sugar Diabetes, High Cholesterol Ischemic Heart Disease, Stroke, HIV/AIDS and Emphysema (ii) chronic manageable conditions like Arthritis, Chronic Bronchitis, Asthma, Joint Pain, Gall Bladder Diseases, Stomach Ulcers, Back Problems of any kind and (iii) mental health issues like Alzheimer’s Disease and Other Dementias, depression and anxiety, Attention Deficit Hyperactivity Disorder (ADHD)/Attention Deficit Disorder (ADD) (2) if the respondents sought care for a reported condition (hospital stay, outpatient visit, emergency room visit, home health episode, prescribed medication purchase, or medical provider visit) (3) if the respondents reported one or more episodes of disability days due to a specific condition and (4) if the condition was “bothering” the person during the reference period. Health problems as defined by MEPS refers to “physical conditions, accidents, or injuries that affect any part of the body as well as mental or emotional health conditions, such as feeling sad, blue, or anxious about something.” These self-reported conditions are then mapped to International Classification of Diseases (ICD-9-CM) diagnosis codes and further recoded to aggregate clinical classification codes (CCCODEX) by MEPS researchers. The cross-walk file between ICD-9-CM codes and clinical classification codes are published [36]. In order to minimize bias associated with self-reported data, upon completion of the household CAPI interview and obtaining permission from the household survey respondents, a sample of medical providers are contacted by telephone to obtain information that household respondents could not accurately provide [35, 37].

In this paper, chronic physical conditions consisted of self-reported diagnosis of asthma, COPD, diabetes, heart disease, hypertension, arthritis and osteoporosis. Heart disease included heart valve disorders, peri- endo-, and myocarditis, cardiomyopathy, acute myocardial infarction, coronary atherosclerosis and other heart disease, non-specific chest pain, pulmonary heart disease, conduction disorders, cardiac dysrhythmias, congestive heart failure and other and ill-defined heart disease. Arthritis included Infective arthritis and osteomyelitis (except that caused by tuberculosis or sexually transmitted disease), rheumatoid arthritis and related disease, osteoarthritis and other non-traumatic joint disorders. These chronic physical conditions were selected based on prevalence, economic, morbidity and mortality burden [38]. We used three-digit International Classification of Diseases-9th edition-Clinical Modification (ICD-9-CM) and clinical classification codes provided in the medical care event files to identify presence of these conditions.

Key independent variable: depression-anxiety status

Presence of depression and/or anxiety was derived from the Medical Conditions file. We used clinical classification codes to identify depression (code: 657) and anxiety (code: 651). Based on the presence of depression and anxiety we categorized the individuals into 4 groups: 1) Depression only (individuals with only depression and no anxiety); 2) Anxiety Only (individuals with only anxiety and no depression); 3) Comorbid depression and anxiety (individuals with both depression and anxiety); and 4) No depression and no anxiety (individuals with neither depression nor anxiety).

Other independent variables

We also included variables that may be associated with risk for chronic physical conditions. These included demographic factors (gender, age, race/ethnicity, and metro status), socio-economic status (education and poverty status), access to care (health insurance), and modifiable life-style risk factors. Modifiable life-style risk factors were overweight and obesity as measured by Body Mass Index (BMI) values, lack of physical activity, current smoking status. BMI was grouped into three categories: normal BMI (18.5 kg/m2-24.9 kg/m2); overweight (25 kg/m2-29.9 kg/m2); and obese (≥ 30 kg/m2 ) [39]. Lack of physical activity was measured as a binary variable based on vigorous activity at least three days a week (Yes/No). Current smoking status was grouped as current smoker, former smoker, and never smoked.

Statistical techniques

Significant bivariate group differences in the association between depression-anxiety status and chronic physical conditions were tested with chi-square statistic. Logistic regressions are commonly used to estimate the association between binary dependent variable and other independent variables. However, the AORs from logistic regressions cannot be interpreted as risk when the disease prevalence is high (i.e. >10%), as is the case for many of our chronic conditions, since AORs fail to give approximations for risk [40]. Simulation studies have shown that complementary log-log (CLL) regression models can be used as an alternative statistical model for estimating multivariable-adjusted prevalence ratios and their confidence intervals [41]. The CLL regression models can be easily implemented with standard statistical software packages such as Statistical Analysis Software (SAS). In the current study, coefficients from CLL regressions were exponentiated to summarize the excess risk of chronic physical conditions associated with depression-anxiety status [42]. The CLL regressions included all the independent variables mentioned in the “Measures” section. For our key independent variable, depression-anxiety status, “no depression and no anxiety” group was used as the reference category. All analyses accounted for the complex design of MEPS. As we tested our hypothesis for seven different chronic physical conditions, the significance level for multiple comparisons was controlled by applying the Bonferroni correction for multiple comparisons and p ≤ 0.007 was considered statistically significant. Analyses were performed in SAS 9.3 [43].

Results

In our study sample of young adults between the ages of 22 and 64 years (data not presented in tabular form), majority of the study sample were white (66%), women (51%), lived in a metro area (85%), and had private insurance (73%). Forty-eight percent had college education and 43% had incomes representing 400% or more federal poverty line. Nearly 1 in five individuals were current smokers and 60% exercised more than 3 time each week; overall, 31% reported a normal BMI; 35% were classified as overweight; and 30% were categorized as obese based on BMI values.

Table 1 presents the distribution of study sample characteristics by depression-anxiety anxiety status. Overall, 7% had depression only, 5% had anxiety only and 3% had comorbid depression and anxiety. We observed significant group differences in depression-anxiety status by all the variables included in the study. A higher proportion of women (3.7%) than men (1.6%) reported comorbid depression and anxiety compared to no depression and no anxiety. A higher proportion of individuals with comorbid depression and anxiety were poor compared to those who had high income (4.8% vs. 1.9%), were obese as compared to those with normal weight (3.6% vs. 2.4%), were current smokers compared to individuals who never smoked or were former smokers (4.5% vs. 2.3%). Similar findings were noted for depression only and anxiety only categories.
Table 1

Description of study sample by depression-anxiety status medical expenditure panel survey, 2007-2009

 

Depression only

Anxiety only

Comorbid depression and anxiety

No depression and no anxiety

 
 

N

Wt%

N

Wt%

N

Wt%

N

Wt%

P-value

ALL

2,326

7.3

1,719

5.6

849

2.7

28,348

84.4

 

Gender

        

< .0001

Women

1,610

9.5

1,121

7.1

618

3.7

14,452

79.7

 

Men

716

5.2

598

4.0

231

1.6

13,896

89.2

 

Race/ethnicity

        

< .0001

White

1,454

8.6

1,065

6.5

568

3.2

12,704

81.8

 

African American

309

4.7

214

3.5

95

1.7

5,256

90.1

 

Latino

454

5.3

332

4.1

145

1.6

7,845

89.1

 

Others

109

4.6

108

3.9

41

1.6

2,543

89.9

 

Age in years

        

< .0001

21-39

749

5.6

663

5.2

265

2.0

12,414

87.2

 

40-49

633

7.9

449

5.7

217

2.8

7,199

83.5

 

50 – 64

944

9.1

607

6.0

367

3.4

8,735

81.5

 

Metro status

        

0.0048

Metro

1,919

7.1

1,466

5.6

698

2.6

24,468

84.7

 

Not Metro

407

8.8

253

5.4

151

3.1

3,880

82.8

 

Education

        

0.0063

Less than high school

505

8.1

306

5.0

196

3.1

5,725

83.8

 

High school

748

8.0

498

5.5

253

2.8

8,629

83.7

 

College

1,063

6.8

911

5.8

395

2.5

13,724

84.8

 

Health insurance

        

< .0001

Private

1,347

6.8

1,204

5.9

460

2.3

18,452

85

 

Public

566

15

255

6.7

287

8.2

2,973

70

 

Uninsured

413

6.2

260

3.7

102

1.7

6,923

88.4

 

Poverty status

        

< .0001

Poor

515

10.5

271

5.9

234

4.8

4,222

78.7

 

Near poor

525

8.4

305

5.1

173

3.2

5,811

83.4

 

Middle income

625

6.7

561

5.9

243

2.7

8,897

84.6

 

High income

661

6.6

582

5.4

199

1.9

9,418

86.1

 

Body mass index categories

        

< .0001

Normal

603

6.0

517

5.7

238

2.4

8,830

85.9

 

Overweight

688

6.3

559

5.0

243

2.1

10,120

86.5

 

Obese

980

10.0

602

6.1

351

3.6

8,520

80.2

 

Smoking status

        

< .0001

Current smoker

650

10.2

415

7.0

284

4.5

5,011

78.3

 

Former/never smoked

1,529

6.7

1,216

5.4

529

2.3

21,037

85.6

 

Physical activity

        

< .0001

Vigorous activity at least 3 days/week

1,062

5.8

916

5.2

360

2.0

16,394

86.9

 

Other

1,255

9.7

796

6.3

486

3.7

11,630

80.3

 

Note: Study sample comprised of adults aged 22–64 years alive during the calendar year without self-reported diagnosis of schizophrenia, psychoses, attention deficit hyper activity disorders, adjustment disorders, substance abuse disorders and personality disorders.

Wt: Weighted.

Significant if p < =0.007.

Rates of chronic physical conditions by depression-anxiety status are presented in Table 2. The percentage of individuals with chronic physical conditions was highest in the group with comorbid depression and anxiety, followed by those with only depression only, anxiety only and those with no depression and no anxiety. Individuals with comorbid depression and anxiety had the highest prevalence of arthritis (39%) followed by hypertension (35%), COPD (21%), heart disease (17%), diabetes (15%), asthma (14%) and osteoporosis (4%).
Table 2

Number and weighted percentage of chronic physical conditions by depression-anxiety status medical expenditure panel survey, 2007-2009

 

Depression only

Anxiety only

Comorbid depression and anxiety

No depression and no anxiety

 
 

N

Wt%

N

Wt%

N

Wt%

N

Wt%

P-value

Arthritis

831

34.3

481

27.2

360

38.8

4,114

14.8

< .0001

Asthma

258

10.2

131

7.2

131

13.8

1,195

4.2

< .0001

COPD

403

16.7

235

13.7

196

21.3

1,925

7.1

< .0001

Diabetes

348

13.2

165

8.2

139

14.7

2,063

6.2

< .0001

Heart disease

301

11.2

195

10.5

149

16.9

1,449

5.3

< .0001

Hypertension

786

30.6

470

25.5

313

34.5

5,092

16.9

< .0001

Osteoporosis

50

2.1

32

2.0

26

3.5

199

0.8

< .0001

Note: Study sample comprised of adults, 22–64 years of age, alive during the calendar year and without self-reported diagnosis of schizophrenia, psychoses, attention deficit hyper activity disorders, adjustment disorders, substance abuse disorders and personality disorders.

COPD: Chronic Obstructive Pulmonary Disease; Wt: Weighted.

Significant if p < =0.007.

In Table 3, we present the adjusted risk ratios (ARRs) and 95% Confidence intervals (CI) from CLL regressions for depression-anxiety status after controlling for demographic, socio-economic, access to care and modifiable life-style risk factors. Results from CLL regressions indicated that compared to individuals with no depression and no anxiety, groups with comorbid depression and anxiety had greater risk of all chronic physical conditions. The ARRs for comorbid depression and anxiety ranged from 2.47 (95% CI: 1.47, 4.15; P = 0.0007) for osteoporosis to 1.64 (95% CI: 1.33, 2.04; P < 0.0001) for diabetes. Presence of depression only was also found to be significantly associated with all chronic conditions except for osteoporosis. ARRs ranged 1.94 (95% CI: 1.75, 2.14; P < 0.0001) for arthritis to 1.49 (95% CI: 1.36, 1.64; P < 0.0001) for heart disease. Individuals with anxiety only were found to have a higher risk for arthritis (ARR: 1.71, 95% CI: 1.54, 1.90; P < 0.0001), COPD (ARR: 1.62, 95% CI: 1.37, 1.91; P < 0.0001), heart disease (ARR: 1.74, 95% CI: 1.45, 2.09; P < 0.0001) and hypertension (ARR: 1.48, 95% CI: 1.31, 1.68; P < 0.0001).
Table 3

Associations between depression-anxiety status and chronic physical conditions a adjusted risk ratios (ARR) and 95% confidence intervals medical expenditure panel survey, 2007 and 2009

 

Depression only

Anxiety only

Comorbid

Depression and anxiety

 

ARR

[95% CI]

P-value

ARR

[95% CI]

P-value

ARR

[95% CI]

P-value

Arthritis

1.94

[1.75,2.14]

<0.0001

1.71

[1.54,1.90]

<0.0001

2.04

[1.79,2.33]

<0.0001

Asthma

1.78

[1.50,2.11]

<0.0001

1.4

[1.13,1.75]

0.0023

2.16

[1.66,2.81]

<0.0001

COPD

1.76

[1.54,2.02]

<0.0001

1.62

[1.37,1.91]

<0.0001

2.05

[1.68,2.49]

<0.0001

Diabetes

1.59

[1.37,1.84]

<0.0001

1.21

[1.00,1.47]

0.0457

1.64

[1.33,2.02]

<0.0001

Heart disease

1.56

[1.34,1.81]

<0.0001

1.74

[1.45,2.09]

<0.0001

2.16

[1.77,2.63]

<0.0001

Hypertension

1.49

[1.36,1.64]

<0.0001

1.48

[1.31,1.68]

<0.0001

1.66

[1.44,1.93]

<0.0001

Osteoporosis

1.78

[1.22,2.61]

0.0433

1.6

[1.01,2.53]

0.0029

2.47

[1.47,4.15]

0.0007

Note: Analytic sample comprised of adults, 22–64 years of age with no self-reported diagnosis of schizophrenia, psychoses, attention deficit hyper activity disorders, adjustment disorders, substance abuse disorders and personality disorders.

Reference group for multivariable complementary log-log regression estimates: “no depression and no anxiety

aModel Controlled for modifiable lifestyle risk factors (weight-status, physical activity, smoking status), age, gender, race/ethnicity, education, whether residing in a metro area (yes/no) and health insurance.

COPD = Chronic Obstructive Pulmonary Disease.

Significant if P < =0.007.

Secondary analyses

It is plausible that use of psychotropic medications may be independently associated with higher risk of chronic physical conditions compared to those without psychotropic medications use. For example, Paroxetine, a selective serotonin reuptake inhibitors often used to treat depression may hamper the function of vascular endothelial cells by impairing endothelial nitric oxide synthase, thus affecting arterial integrity leading to cardiovascular diseases [44]. Tricyclic antidepressants can affect cardiac conduction and rhythm, and could be cardiotoxic [45] leading to greater risk of developing heart disease. Elevated risk for glucose dysregulation, weight gain and new onset diabetes has been observed with the use of antipsychotic and antidepressants medications [4648]. Both typical and atypical antipsychotic medications are known to induce hyperprolactinemia [49] which leads to bone loss, a major risk factor for osteoporosis [50]. We tested this by additionally including psychotropic medication use in the complementary log-log regression models. Psychotropic medication use was identified from prescription drug files using Multum Lexicon therapeutic categories (category code = 242).

Overall, 11.4% of the study sample used psychotropic medications; 80% of those with comorbid depression and anxiety, 67% of those with depression only, 40% of those with anxiety only and 2.5% of those with no depression and no anxiety had psychotropic medication use. Among those with comorbid depression and anxiety, non-users of psychotropic medication varied by type of chronic physical conditions; among those with diabetes and comorbid depression and anxiety, only 0.4% did not use psychotropic medications; similar findings were noted for hypertension (0.6%), arthritis (0.9%), COPD (1.1%), heart disease (1.2%), arthritis (1.5%) and osteoporosis (1.5%),

When we additionally included use of psychotropic medications along with other independent variables mentioned in the measures section, we found that psychotropic medication use was independently associated with increased risk of arthritis (ARR: 1.28; 95% CI: 1.15-1.42; P < 0.0.0001), diabetes (ARR: 1.51; 95% CI: 1.27-1.78; P < 0.0.0001) and hypertension (ARR: 1.23; 95% CI: 1.13-1.42; P < 0.0.0001).

The association between depression-anxiety status and higher risk of chronic physical conditions remained the same except for diabetes. The association between comorbid depression and anxiety and osteoporosis was no longer statistically significant after controlling for psychotropic medication use. However, one needs to use extreme caution in interpreting these results, because of the very high correlation between psychotropic medication use and depression anxiety status variable (> 0.66) and very small sample size in comorbid depression and anxiety and no psychotropic medication for some of the chronic conditions. Results from these regression models are available from the first author upon request.

Discussion

Our paper examined the excess risk of chronic physical conditions associated with depression and/or anxiety among non-elderly adults after controlling for a comprehensive list of demographic, socio-economic, access to care, and modifiable lifestyle risk factors for chronic conditions. In our study sample of non-elderly adults 15.6% had either depression or anxiety or both. In multivariable regressions, we found that depression-anxiety status was associated with greater risk of asthma, arthritis, COPD, diabetes, heart disease, hypertension, and osteoporosis. While our research focused on the one-way relationship between depression-anxiety status and risk of chronic conditions, one cannot rule out bidirectional associations. Bidirectional association between depression and/or anxiety and risk of many medical illness such as diabetes [1], hypertension, cardiovascular diseases [1, 51], COPD [22, 52], asthma [52], arthritis [53] and osteoporosis [54] has been documented. However, owing to the cross-sectional design used in the study, we were unable to test any bidirectional associations between depression-anxiety status and the risk of chronic physical conditions.

Although not directly analyzed in this study, we can speculate on the reasons for excess risk for chronic physical conditions associated with depression and/or anxiety. Prior research has attributed this excess risk to biological factors [44], use of psychotropic medications [44] as well as access to care issues [55]. Several biological mechanisms including decreased heart rate variability [56, 57], increased platelet aggregation [58], higher levels of inflammatory risk markers (C-reactive protein and interleukin-6) [59] among individuals with depression and/or anxiety may lead to increased risk for cardiovascular diseases. Hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation and sympathetic nervous system stimulation associated with glucose homeostasis are suggested explanations for the observed association of diabetes with depressive symptoms and major depression [60]. The pathogenic mechanisms of COPD and depression and/or anxiety are complex. Common symptomologies such as shortness of breath or dyspnea, and hyperventilation are observed in individuals with COPD as well as panic anxiety [61]. Furthermore, both anxiety and depression are associated with activation of the HPA axis and increased systemic inflammatory responses which may be responsible for increased risk of COPD exacerbations [6266]. Dysregulation of certain stress-sensitive biological processes such as the autonomic nervous system, that contribute to the pathophysiology of both conditions, may explain the association between depression and/or anxiety and asthma [67]. The association between arthritis and depression can be attributed to the relationship between depression and inflammation; various inflammation markers such as C-reactive proteins are positively associated with depression [68]. The association between depression and low bone mineral density certainly helps to explain the risk of osteoporosis in this population [9].

Individuals with depression and/or anxiety may face a wide array of patient-, provider- and system-level barriers, which can restrict access to needed medical care. Such restricted healthcare access may increase the risk of chronic physical conditions. It has been reported that individuals with depression had problems with all four domains of primary care namely access, comprehensiveness, co-ordination and continuity of care [10]. Again individuals with anxiety often lack planned follow up and monitoring, which can be a barrier for effective preventive healthcare to reduce the risk of developing chronic conditions [69]. As primary care use have been shown to be effective in modifying the risk factors for chronic physical conditions [70], lack of appropriate primary care among individuals with depression and/or anxiety can also lead to development of chronic physical conditions. The emerging healthcare delivery models such as patient-centered medical homes and accountable care organizations, in which emphasis has been placed on primary care, [71] may facilitate efforts to reduce the risk of chronic physical conditions. Future research needs to evaluate the success of these emerging healthcare delivery models in effectively reducing the risk of chronic physical conditions in vulnerable individuals with depression and/or anxiety.

Findings from our study indicated that individuals with depression and/or anxiety are more likely to suffer from poor physical health, high rates of obesity and smoking. These findings highlight the need for integrating wellness efforts within mental healthcare settings. In addition, emphasis on physical wellness needs to be part of broader efforts to improve mental health [72]. In order to improve both physical and mental health, primary care services need to be integrated within mental health settings (reverse integration). Randomized trials and experimental studies have provided evidence on the beneficial effects of integrated primary care and mental health care for patients with depression and/or anxiety [73]. In addition to wellness efforts, routine screening for depression and/or anxiety along with co-ordinated mental-health care for those who screen positive for depression and/or anxiety may reduce the risk of chronic physical conditions.

The study had a number of strengths, including nationally representative sample, comprehensive list of independent variables that may affect chronic physical conditions and the ability to analyze the association between depression-anxiety status and a number of chronic physical conditions. We were also able to assess the independent effects of depression only, anxiety only, and comorbid depression and anxiety on risk of chronic conditions. Limitations have to be considered when interpreting the findings of the present study. The study design is retrospective, observational, and cross-sectional and therefore cannot establish causal relationships. Study variables are based on self-reported data which might be subject to reporting-bias. As our study assessed the excess risk of chronic physical conditions among non-elderly adults, the study results are not generalizable to other age groups. Although we adjusted for a large number of risk factors that may affect presence of chronic conditions, some variables such as family history that could contribute to the excess risk of chronic physical conditions were not available. Finally, our study was not immune to the inherent limitations associated with use of secondary data such as measurement errors, errors in data editing and imputation, sampling and non-sampling errors, reporting errors and interviewer effects.

Conclusions

Despite the limitations, our study has made a unique contribution to the literature by analyzing the independent contribution of depression, anxiety, and comorbid depression and anxiety on the risk of having chronic physical conditions, after controlling for demographic, life-style, and other important risk factors. Our study findings confirmed that even after adjusting for modifiable lifestyle risk factors, depression and/or anxiety made an independent contribution to the excess risk for many chronic physical conditions. Our study findings highlight the need to minimize the burden of depression and anxiety either through better surveillance, monitoring and treatment of these conditions, which may in turn contribute to reduction in the risk of developing chronic physical conditions.

Declarations

Acknowledgments

Dr. Sambamoorthi was partially supported with infrastructure by the Collaborative Health Outcomes Research of Therapies and Services (CoHORTS) Grant (1 P20 HS 015390–02). Dr. Sambamoorthi and Ms. Bhattacharya are also members of the Center for Cardiovascular & Respiratory Sciences, West Virginia University.

Authors’ Affiliations

(1)
Department of Pharmaceutical Sciences and Policy, School of Pharmacy, West Virginia University
(2)
Center For Cardiovascular And Respiratory Sciences, West Virginia University
(3)
Department of Biostatistics, University of Texas, MD Anderson Cancer Center

References

  1. Steptoe A: Depression and physical illness. 2007, Cambridge, UK: Cambridge University PressGoogle Scholar
  2. Katon WJ: Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011, 13 (1): 7-23.PubMedGoogle Scholar
  3. Rotella F, Mannucci E: Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry. 2013, 74 (1): 31-37. 10.4088/JCP.12r07922.View ArticlePubMedGoogle Scholar
  4. Wulsin LR, Singal BM: Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003, 65 (2): 201-210. 10.1097/01.PSY.0000058371.50240.E3.View ArticlePubMedGoogle Scholar
  5. Patten SB, Williams JV, Lavorato DH, Campbell NR, Eliasziw M, Campbell TS: Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med. 2009, 71 (3): 273-279. 10.1097/PSY.0b013e3181988e5f.View ArticlePubMedGoogle Scholar
  6. Tolea MI, Black SA, Carter-Pokras OD, Kling MA: Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women. Osteoporos Int. 2007, 18 (3): 315-322. 10.1007/s00198-006-0242-7.View ArticlePubMedGoogle Scholar
  7. Mussolino ME: Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep. 2005, 120 (1): 71-75.PubMedPubMed CentralGoogle Scholar
  8. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS: Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999, 159 (5): 484-490. 10.1001/archinte.159.5.484.View ArticlePubMedGoogle Scholar
  9. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G: Depression and Osteoporosis: A Research Synthesis with Meta-Analysis. Horm Metab Res. 2010, 42 (7): 467-482. 10.1055/s-0030-1252020.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Druss BG, Rask K, Katon WJ: Major depression, depression treatment and quality of primary medical care. Gen Hosp Psychiatry. 2008, 30 (1): 20-25. 10.1016/j.genhosppsych.2007.08.015.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Rugulies R: Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002, 23 (1): 51-61. 10.1016/S0749-3797(02)00439-7.View ArticlePubMedGoogle Scholar
  12. Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan. Diabetes Care. 2008, 31 (12): 2383-2390. 10.2337/dc08-0985.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Covey LS: Tobacco cessation among patients with depression. Prim Care. 1999, 26 (3): 691-706. 10.1016/S0095-4543(05)70124-X.View ArticlePubMedGoogle Scholar
  14. Covey LS, Glassman AH, Stetner F: Major depression following smoking cessation. Am J Psychiatry. 1997, 154 (2): 263-265.View ArticlePubMedGoogle Scholar
  15. Covey LS, Glassman AH, Stetner F: Cigarette smoking and major depression. J Addict Dis. 1998, 17 (1): 35-46. 10.1300/J069v17n01_04.View ArticlePubMedGoogle Scholar
  16. Rutledge T, Hogan BE: A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med. 2002, 64 (5): 758-766. 10.1097/01.PSY.0000031578.42041.1C.PubMedGoogle Scholar
  17. Johannessen L, Strudsholm U, Foldager L, Munk-Jørgensen P: Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006, 95 (1): 13-17.View ArticlePubMedGoogle Scholar
  18. Engum A: The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007, 62 (1): 31-38. 10.1016/j.jpsychores.2006.07.009.View ArticlePubMedGoogle Scholar
  19. Edwards LE, Mezuk B: Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res. 2012, 73 (6): 418-423. 10.1016/j.jpsychores.2012.09.018.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Dorn LD, Susman EJ, Pabst S, Huang B, Kalkwarf H, Grimes S: Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls. Arch Pediatr Adolesc Med. 2008, 162 (12): 1181-1188. 10.1001/archpedi.162.12.1181.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Jacobs J, Andersson G, Bell J, Weinstein S, Dormans J, Gnatz S, Lane N, Puzas J, St Clair E, Yelin E: Burden of musculoskeletal diseases in the United States: Prevalence, societal, and economic cost. 2008, Rosemont: American Academy of Orthopaedic SurgeonsGoogle Scholar
  22. Atlantis E, Fahey P, Cochrane B, Smith S: Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest. 2013, 144: 766-777. 10.1378/chest.12-1911.View ArticlePubMedGoogle Scholar
  23. Scott KM, Oakley Browne MA, McGee MA, Wells JE: Mental-physical comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry. 2006, 40 (10): 882-888.PubMedGoogle Scholar
  24. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003, 289 (23): 3095-3105. 10.1001/jama.289.23.3095.View ArticlePubMedGoogle Scholar
  25. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, Nolen WA, Zitman FG, Beekman AT, Penninx BW: Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011, 72 (3): 341-348. 10.4088/JCP.10m06176blu.View ArticlePubMedGoogle Scholar
  26. Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R, et al: Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord. 2007, 103 (1–3): 113-120.View ArticlePubMedGoogle Scholar
  27. Stunkard AJ, Faith MS, Allison KC: Depression and obesity. Biol Psychiatry. 2003, 54 (3): 330-337. 10.1016/S0006-3223(03)00608-5.View ArticlePubMedGoogle Scholar
  28. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB: Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry. 2004, 65 (5): 634-651. 10.4088/JCP.v65n0507. quiz 730View ArticlePubMedGoogle Scholar
  29. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, van Eijk JT: Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing. 2003, 32 (1): 81-87. 10.1093/ageing/32.1.81.View ArticlePubMedGoogle Scholar
  30. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G: Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health. 1998, 88 (10): 1518-1522. 10.2105/AJPH.88.10.1518.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Ströhle A: Physical activity, exercise, depression and anxiety disorders. J Neural Transm. 2009, 116 (6): 777-784. 10.1007/s00702-008-0092-x.View ArticlePubMedGoogle Scholar
  32. American Diabetic Association: The Cardiometabolic Risk Initiative. URL: http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=60382
  33. National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health: Arthritis-Risk Factors. URL: http://www.cdc.gov/arthritis/basics/risk_factors.htm
  34. World Health Organization- Global Alliance against Chronic Respiratory Diseases: Risk Factors for Chronic Respiratory Diseases. URL: http://www.who.int/gard/publications/Risk%20factors.pdf
  35. Medical Expenditure Panel Survey Data Documentation: MEPS HC-129:. 2007, URL: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h129/h129doc.pdf, Full Year Consolidated Data FileGoogle Scholar
  36. Medical Expenditure Panel Survey Clinical Classification Code to ICD-9-CM Code Crosswalk. URL: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h128/h128_icd9codes.shtml
  37. Medical Expenditure Panel Survey Data Documentation: MEPS HC-113:. 2007, URL: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h113/h113doc.pdf, Full Year Consolidated Data FileGoogle Scholar
  38. National Heart, Lung and Blood Institute Overview and Planning Documents . 2012, URL: http://www.nhlbi.nih.gov/about/factbook/chapter4.htm, Fact Book. Disease Statisics
  39. About BMI for Adults. URL: http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html
  40. Altman DG, Deeks JJ, Sackett DL: Odds ratios should be avoided when events are common. BMJ. 1998, 317 (7168): 1318-View ArticlePubMedPubMed CentralGoogle Scholar
  41. Penman AD, Johnson WD: Complementary log-log regression for the estimation of covariate-adjusted prevalence ratios in the analysis of data from cross-sectional studies. Biometrical J Biometrische Zeitschrift. 2009, 51 (3): 433-442. 10.1002/bimj.200800236.View ArticleGoogle Scholar
  42. Cummings P: The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009, 163 (5): 438-10.1001/archpediatrics.2009.31.View ArticlePubMedGoogle Scholar
  43. SAS Institute, Cary, NC; RTI, Research Triangle Park, NC. In. North Carolina US: SAS Institute
  44. Broadley A, Korszun A, Jones C, Frenneaux M: Arterial endothelial function is impaired in treated depression. Heart. 2002, 88 (5): 521-523. 10.1136/heart.88.5.521.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Cohen HW, Gibson G, Alderman MH: Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000, 108 (1): 2-8. 10.1016/S0002-9343(99)00301-0.View ArticlePubMedGoogle Scholar
  46. Bhattacharjee S, Bhattacharya R, Kelley GA, Sambamoorthi U: Antidepressant use and new‒onset diabetes: a systematic review and meta‒analysis. Diabetes Metab Res Rev. 2013, 29 (4): 273-284. 10.1002/dmrr.2393.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Cohen D: Atypical antipsychotics and new onset diabetes mellitus: an overview of the literature. Pharmacopsychiatry. 2004, 37: 1-11.PubMedGoogle Scholar
  48. Hasnain M, Hollett B: Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Postgrad Med. 2012, 124 (4): 154-10.3810/pgm.2012.07.2577.View ArticlePubMedGoogle Scholar
  49. Madhusoodanan S, Parida S, Jimenez C: Hyperprolactinemia associated with psychotropics—a review. Hum Psychopharm clin. 2010, 25 (4): 281-297. 10.1002/hup.1116.View ArticleGoogle Scholar
  50. Vartej P, Poiana C, Vartej I: Effects of hyperprolactinemia on osteoporotic fracture in premenopausal women. Gynecol Endocrinol. 2001, 15 (1): 43-47.View ArticlePubMedGoogle Scholar
  51. Player MS, Peterson LE: Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med. 2011, 41 (4): 365-377. 10.2190/PM.41.4.f.View ArticlePubMedGoogle Scholar
  52. Jain A, Lolak S: Psychiatric aspects of chronic lung disease. Curr Psychiatry Rep. 2009, 11 (3): 219-225. 10.1007/s11920-009-0034-9.View ArticlePubMedGoogle Scholar
  53. Bruce TO: Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep. 2008, 10 (3): 258-264. 10.1007/s11920-008-0042-1.View ArticlePubMedGoogle Scholar
  54. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan K, Nemeroff CB, Bremner JD, Carney RM, Coyne JC: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005, 58 (3): 175-189. 10.1016/j.biopsych.2005.05.001.View ArticlePubMedGoogle Scholar
  55. Robson D, Gray R: Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud. 2007, 44 (3): 457-466. 10.1016/j.ijnurstu.2006.07.013.View ArticlePubMedGoogle Scholar
  56. Gorman JM, Sloan RP: Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000, 140 (4): 77-83. 10.1067/mhj.2000.109981.View ArticlePubMedGoogle Scholar
  57. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999, 99 (16): 2192-2217. 10.1161/01.CIR.99.16.2192.View ArticlePubMedGoogle Scholar
  58. Pollock BG, Laghrissi-Thode F, Wagner WR: Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol. 2000, 20 (2): 137-10.1097/00004714-200004000-00004.View ArticlePubMedGoogle Scholar
  59. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002, 90 (12): 1279-1283. 10.1016/S0002-9149(02)02863-1.View ArticlePubMedGoogle Scholar
  60. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003, 54: 317-329. 10.1016/S0006-3223(03)00569-9.View ArticlePubMedGoogle Scholar
  61. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB: Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004, 58 (1): 65-70. 10.1080/08039480310000824.View ArticlePubMedGoogle Scholar
  62. Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ: Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008, 106 (3): 249-255. 10.1016/j.jad.2007.07.002.View ArticlePubMedGoogle Scholar
  63. Cameron OG, Abelson JL, Young EA: Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biol Psychiatry. 2004, 56 (11): 875-883. 10.1016/j.biopsych.2004.08.007.View ArticlePubMedGoogle Scholar
  64. Ehlert U, Gaab J, Heinrichs M: Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol. 2001, 57 (1–3): 141-152.View ArticlePubMedGoogle Scholar
  65. Joynt KE, Whellan DJ, O’Connor CM: Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail. 2004, 10 (3): 258-271. 10.1016/j.cardfail.2003.09.008.View ArticlePubMedGoogle Scholar
  66. Varghese FP, Brown ES: The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians. Prim Care Companion J Clin Psychiatry. 2001, 3 (4): 151-155. 10.4088/PCC.v03n0401.View ArticlePubMedPubMed CentralGoogle Scholar
  67. Van Lieshout RJ, Bienenstock J, MacQueen GM: A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med. 2009, 71 (2): 187-195. 10.1097/PSY.0b013e3181907012.View ArticlePubMedGoogle Scholar
  68. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S: Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Care Res. 2009, 61 (8): 1018-1024. 10.1002/art.24647.View ArticleGoogle Scholar
  69. Roy-Byrne PP, Wagner A: Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004, 65: 20-PubMedGoogle Scholar
  70. Harris M: The role of primary health care in preventing the onset of chronic disease, with a particular focus on the lifestyle risk factors of obesity, tobacco and alcohol. 2008, National Preventative Health Taskforce: CanberraGoogle Scholar
  71. Rittenhouse DR, Shortell SM: The patient-centered medical home. JAMA. 2009, 301 (19): 2038-2040. 10.1001/jama.2009.691.View ArticlePubMedGoogle Scholar
  72. Druss BG, Bornemann TH: Improving health and health care for persons with serious mental illness: the window for US federal policy change. JAMA. 2010, 303 (19): 1972-1973. 10.1001/jama.2010.615.View ArticlePubMedGoogle Scholar
  73. Butler M, Kane RL, McAlpine D, Kathol RG, Fu SS, Hagedorn H, Wilt TJ: Integration of mental health/substance abuse and primary care No. 173 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 09-E003. 2008, Rockville, MD: Agency for Healthcare Research and QualityGoogle Scholar
  74. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-244X/14/10/prepub

Copyright

© Bhattacharya et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement